Top Markets
#1 Siacoin Siacoin +26.17%
#2 Official Trump Official Trump +26.06%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +19.20%
#4 EXOD EXOD +18.93%
#5 MowCat MowCat +17.75%
#6 Unit Pump Unit Pump +16.53%
#7 Pump.fun Pump.fun +16.53%
#8 Melania Meme Melania Meme +16.02%
#9 Siren Siren +15.43%
#10 Mubarak Mubarak +14.58%
Coin of the day
Siacoin Siacoin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Modern Chinese Medicine Group Co., Ltd. Modern Chinese Medicine Group Co., Ltd.

Modern Chinese Medicine Group Co., Ltd.

1643
Rang in Aktien #23125
As an investment holding company, Modern Chinese Medicine Group Co., Ltd.... As an investment holding company, Modern Chinese Medicine Group Co., Ltd. manufactures and distributes traditional Chinese pharmaceutical products, primarily targeting the middle-aged and elderly populations across the People's Republic of China. Its extensive product line provides treatments for a wide array of health issues, including qi deficiency, blood stasis, cardiovascular and cerebrovascular conditions, digestive and gastrointestinal ailments, gynecological problems, as well as disorders affecting the respiratory and nervous systems. Established in 1986, the enterprise maintains its principal offices in Chengde, China, and operates as a subsidiary of Modern Biotechnology Group Holdings Co., Ltd.
Aktienkurs
$0.1087373
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$78.29M
Veränderung (1 Tag)
3.66%
Veränderung (1 Jahr)
18.02%
Land
CN
Handel Modern Chinese Medicine Group Co., Ltd. (1643)

Kategorie

Healthcare
P/S-Verhältnis für Modern Chinese Medicine Group Co., Ltd. (1643)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Modern Chinese Medicine Group Co., Ltd. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Modern Chinese Medicine Group Co., Ltd. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
10.24 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
14.89 -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT